LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
01 1LGM Pharma
02 1FARMAK, a.s
03 1Midas Pharma
04 1TAPI Technology & API Services
05 1Alchymars ICM SM
06 2Alembic Pharmaceuticals Limited
07 2Apotex Pharmachem
08 1Bristol Myers Squibb
09 1Cilag AG
10 2Ipca Laboratories
11 1Magle Chemoswed
12 1Napp Technologies
13 1Nycomed Austria GmbH
14 1Oceanic Laboratories
15 1Qilu Antibiotics Pharmaceutical Co., Ltd.
16 1Qilu Pharmaceutical
17 1Qingdao Qingmei Biotech
18 1Raks Pharma
19 1SLN Pharmachem
20 2Taro Pharmaceutical Industries
21 1Teva Pharmaceutical Industries
22 1Trifarma
23 1Unichem Laboratories Limited
24 3Venkata Narayana Active Ingredients
25 1Zydus Lifesciences
01 1Austria
02 2Canada
03 3China
04 1Czech Republic
05 1Germany
06 13India
07 2Israel
08 1Italy
09 1Sweden
10 1Switzerland
11 5U.S.A
01 13Active
02 6Inactive
03 12Blank
01 1Expired
02 10Valid
03 3Withdrawn by Holder
04 17Blank
01 31Blank
01 1WC-0082
02 1WC-0091
03 1WC-0291
04 1WC-0291n
05 1WC-0305
06 1WC-0348
07 25Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22132
Submission : 2008-11-11
Status : Active
Type : II
NDC Package Code : 63278-1058
Start Marketing Date : 1983-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : ASMF |
Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.
Certificate Number : R1-CEP 2014-183 - Rev 00
Issue Date : 2021-07-13
Type : Chemical
Substance Number : 698
Status : Valid
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12269
Submission : 1996-12-16
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21925
Submission : 2008-08-25
Status : Active
Type : II
Certificate Number : R1-CEP 2008-321 - Rev 01
Issue Date : 2018-11-16
Type : Chemical
Substance Number : 698
Status : Valid
Date of Issue : 2021-03-12
Valid Till : 2024-01-24
Written Confirmation Number : WC-0291n
Address of the Firm :
NDC Package Code : 52038-002
Start Marketing Date : 2010-07-16
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36406
Submission : 2021-10-14
Status : Active
Type : II
NDC Package Code : 52038-002
Start Marketing Date : 2010-07-16
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23289
Submission : 2009-11-20
Status : Active
Type : II
Date of Issue : 2021-09-06
Valid Till : 2020-04-22
Written Confirmation Number : WC-0305
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21926
Submission : 2008-08-25
Status : Inactive
Type : II
Certificate Number : CEP 2021-450 - Rev 00
Issue Date : 2024-02-05
Type : Chemical
Substance Number : 699
Status : Valid
Date of Issue : 2018-01-25
Valid Till : 2021-01-24
Written Confirmation Number : WC-0291
Address of the Firm :
NDC Package Code : 52038-002
Start Marketing Date : 2010-07-16
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12117
Submission : 1996-08-27
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2467
Submission : 1975-06-10
Status : Inactive
Type : II
We have 25 companies offering Warfarin Sodium
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?